BRPI0509211A - uso de compostos de peptìdeo para o tratamento de dor em neuropatia diabética - Google Patents
uso de compostos de peptìdeo para o tratamento de dor em neuropatia diabéticaInfo
- Publication number
- BRPI0509211A BRPI0509211A BRPI0509211-6A BRPI0509211A BRPI0509211A BR PI0509211 A BRPI0509211 A BR PI0509211A BR PI0509211 A BRPI0509211 A BR PI0509211A BR PI0509211 A BRPI0509211 A BR PI0509211A
- Authority
- BR
- Brazil
- Prior art keywords
- pain
- treatment
- diabetic neuropathy
- peptide compounds
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
USO DE COMPOSTOS DE PEPTìDEO PARA O TRATAMENTO DE DOR EM NEUROPATIA DIABéTICA. A presente invenção refere-se ao uso de compostos para o tratamento de dor em neuropatia diabética dolorosa, de preferência em polineuropatia sensória distal diabética.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55649904P | 2004-03-26 | 2004-03-26 | |
EP04007360A EP1579858A1 (en) | 2004-03-26 | 2004-03-26 | Novel use of peptide compounds for treating pain in painful diabetic neuropathy |
PCT/EP2005/003176 WO2005092313A1 (en) | 2004-03-26 | 2005-03-24 | Novel use of peptide compounds for treating pain in painful diabetic neuropathy |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0509211A true BRPI0509211A (pt) | 2007-08-28 |
Family
ID=34854637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0509211-6A BRPI0509211A (pt) | 2004-03-26 | 2005-03-24 | uso de compostos de peptìdeo para o tratamento de dor em neuropatia diabética |
Country Status (15)
Country | Link |
---|---|
US (1) | US20060100157A1 (pt) |
EP (2) | EP1579858A1 (pt) |
JP (1) | JP2007530493A (pt) |
CN (1) | CN1938010B (pt) |
AU (1) | AU2005226928B2 (pt) |
BR (1) | BRPI0509211A (pt) |
CA (1) | CA2558311A1 (pt) |
EA (1) | EA012176B1 (pt) |
MX (1) | MXPA06010995A (pt) |
NZ (1) | NZ549668A (pt) |
SG (1) | SG151309A1 (pt) |
TW (1) | TW200701977A (pt) |
UA (1) | UA90467C2 (pt) |
WO (1) | WO2005092313A1 (pt) |
ZA (1) | ZA200607269B (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1243262B1 (en) | 2001-03-20 | 2006-05-31 | Schwarz Pharma Ag | Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain |
PT1243263E (pt) * | 2001-03-21 | 2003-03-31 | Sanol Arznei Schwarz Gmbh | Nova utilizacao de uma classe peptidica de composto para o tratamento de alodinia ou de outros tipos diferentes de dor cronica ou fantasma |
DE602004020657D1 (de) | 2003-12-02 | 2009-05-28 | Sanol Arznei Schwarz Gmbh | Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen |
US20070042969A1 (en) * | 2004-03-26 | 2007-02-22 | Srz Properties, Inc. | Combination therapy for pain in painful diabetic neuropathy |
US20100256179A1 (en) * | 2004-03-26 | 2010-10-07 | Ucb Pharma Gmbh | Combination therapy for pain in painful diabetic neuropathy |
CN1950101B (zh) | 2004-04-16 | 2011-03-30 | 舒沃茨药物股份公司 | 肽化合物用于预防和治疗慢性头痛的用途 |
EP1604655A1 (en) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating pain in trigeminal neuralgia |
NZ552651A (en) | 2004-08-27 | 2010-07-30 | Sanol Arznei Schwarz Gmbh | Novel use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
EP1642889A1 (en) * | 2004-10-02 | 2006-04-05 | Schwarz Pharma Ag | Improved synthesis scheme for lacosamide |
US20060252749A1 (en) * | 2005-01-28 | 2006-11-09 | Srz Properties, Inc. | Lacosamide for add-on therapy of psychosis |
US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
EP1754476A1 (en) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia |
US7902401B2 (en) * | 2006-12-14 | 2011-03-08 | Nps Pharmaceuticals, Inc. | Fluorinated compounds |
GB0603008D0 (en) * | 2006-02-14 | 2006-03-29 | Portela & Ca Sa | Method |
JP2009539792A (ja) * | 2006-06-08 | 2009-11-19 | シュヴァルツ・ファーマ・アーゲー | 疼痛の医学的状態のための治療組合せ |
EP1873527A1 (en) * | 2006-06-30 | 2008-01-02 | Schwarz Pharma Ag | Method for identifying CRMP modulators |
AU2007260207B2 (en) | 2006-06-15 | 2012-11-08 | Ucb Pharma Gmbh | Pharmaceutical composition with synergistic anticonvulsant effect |
CN101466390B (zh) | 2006-06-15 | 2014-03-12 | 优时比制药有限公司 | 用于治疗难治性癫痫持续状态的肽类化合物 |
US8450336B2 (en) * | 2006-12-14 | 2013-05-28 | Nps Pharmaceuticals, Inc | Use of D-serine derivatives for the treatment of anxiety disorders |
EP2509939A4 (en) * | 2009-09-23 | 2013-09-18 | Univ North Carolina | NOVEL N-BENZYLAMIDE SUBSTITUTED DERIVATIVES OF 2- (ACYLAMIDO) ACETIC ACID AND 2- (ACYLAMIDO) PROPIONIC ACIDS: POWERFUL NEUROLOGIC AGENTS |
EP2496220B1 (en) | 2009-11-03 | 2019-10-16 | Lupin Limited | Modified release formulation of lacosamide |
AU2011335415B2 (en) | 2010-12-02 | 2016-05-19 | Ucb Pharma Gmbh | Once daily formulation of lacosamide |
EP2468261A1 (en) | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulation of lacosamide |
CA3008170A1 (en) | 2015-12-30 | 2017-07-06 | Adamas Pharmaceuticals, Inc. | Methods and compositions for the treatment of seizure-related disorders |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378729A (en) * | 1985-02-15 | 1995-01-03 | Research Corporation Technologies, Inc. | Amino acid derivative anticonvulsant |
US5585358A (en) * | 1993-07-06 | 1996-12-17 | Yissum Research Development Corporation Of The Hebrew University Of Jerusalem | Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents |
US6589994B1 (en) * | 1996-08-30 | 2003-07-08 | Nps Pharmaceuticals, Inc. | Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound |
SI1311256T1 (sl) * | 2000-08-17 | 2005-12-31 | Teva Pharma | Uporaba derivatov amidov valprojske kisline in amidov 2-valproenske kisline za zdravljenje ali preprecevanje bolecin in/ali glavobolnih motenj |
DK1365787T3 (da) * | 2000-08-25 | 2007-07-23 | Res Corp Technologies Inc | Anvendelse af aminosyre-holdige, krampestillende midler til behandling af smerte |
EP1243262B1 (en) * | 2001-03-20 | 2006-05-31 | Schwarz Pharma Ag | Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain |
PT1243263E (pt) * | 2001-03-21 | 2003-03-31 | Sanol Arznei Schwarz Gmbh | Nova utilizacao de uma classe peptidica de composto para o tratamento de alodinia ou de outros tipos diferentes de dor cronica ou fantasma |
DE602004020657D1 (de) * | 2003-12-02 | 2009-05-28 | Sanol Arznei Schwarz Gmbh | Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen |
US20060009384A1 (en) * | 2003-12-05 | 2006-01-12 | David Rudd | Novel use of peptide compounds for treating status epilepticus or related conditions |
US20070042969A1 (en) * | 2004-03-26 | 2007-02-22 | Srz Properties, Inc. | Combination therapy for pain in painful diabetic neuropathy |
CN1950101B (zh) * | 2004-04-16 | 2011-03-30 | 舒沃茨药物股份公司 | 肽化合物用于预防和治疗慢性头痛的用途 |
EP1604654A1 (en) * | 2004-05-18 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating dyskinesia |
EP1604656A1 (en) * | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS) |
US7427601B2 (en) * | 2004-06-24 | 2008-09-23 | Schwarz Pharma Ag | Method for treating tremor |
EP1642889A1 (en) * | 2004-10-02 | 2006-04-05 | Schwarz Pharma Ag | Improved synthesis scheme for lacosamide |
US20060252749A1 (en) * | 2005-01-28 | 2006-11-09 | Srz Properties, Inc. | Lacosamide for add-on therapy of psychosis |
EP1754476A1 (en) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia |
US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
US20070048372A1 (en) * | 2005-08-18 | 2007-03-01 | Srz Properties, Inc. | Method for treating non-inflammatory osteoarthritic pain |
-
2004
- 2004-03-26 EP EP04007360A patent/EP1579858A1/en not_active Withdrawn
-
2005
- 2005-03-24 UA UAA200610139A patent/UA90467C2/ru unknown
- 2005-03-24 SG SG200902059-5A patent/SG151309A1/en unknown
- 2005-03-24 EA EA200601777A patent/EA012176B1/ru not_active IP Right Cessation
- 2005-03-24 NZ NZ549668A patent/NZ549668A/en unknown
- 2005-03-24 BR BRPI0509211-6A patent/BRPI0509211A/pt not_active IP Right Cessation
- 2005-03-24 CN CN2005800097824A patent/CN1938010B/zh not_active Expired - Fee Related
- 2005-03-24 JP JP2007504367A patent/JP2007530493A/ja active Pending
- 2005-03-24 AU AU2005226928A patent/AU2005226928B2/en not_active Ceased
- 2005-03-24 EP EP05716372A patent/EP1737437A1/en not_active Withdrawn
- 2005-03-24 MX MXPA06010995A patent/MXPA06010995A/es active IP Right Grant
- 2005-03-24 WO PCT/EP2005/003176 patent/WO2005092313A1/en active Application Filing
- 2005-03-24 CA CA002558311A patent/CA2558311A1/en not_active Abandoned
- 2005-03-25 US US11/089,441 patent/US20060100157A1/en not_active Abandoned
- 2005-07-11 TW TW094123447A patent/TW200701977A/zh unknown
-
2006
- 2006-08-31 ZA ZA200607269A patent/ZA200607269B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU2005226928A1 (en) | 2005-10-06 |
WO2005092313A1 (en) | 2005-10-06 |
ZA200607269B (en) | 2008-04-30 |
TW200701977A (en) | 2007-01-16 |
MXPA06010995A (es) | 2007-04-16 |
EA200601777A1 (ru) | 2007-02-27 |
EP1579858A1 (en) | 2005-09-28 |
CA2558311A1 (en) | 2005-10-06 |
CN1938010A (zh) | 2007-03-28 |
CN1938010B (zh) | 2011-01-19 |
EA012176B1 (ru) | 2009-08-28 |
US20060100157A1 (en) | 2006-05-11 |
NZ549668A (en) | 2010-07-30 |
JP2007530493A (ja) | 2007-11-01 |
UA90467C2 (ru) | 2010-05-11 |
EP1737437A1 (en) | 2007-01-03 |
SG151309A1 (en) | 2009-04-30 |
AU2005226928B2 (en) | 2010-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0509211A (pt) | uso de compostos de peptìdeo para o tratamento de dor em neuropatia diabética | |
BRPI0510043A (pt) | método de tratamento de dor neuropática usando antagonista de receptor crth2 | |
BRPI0618239A8 (pt) | uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos | |
BRPI0810354A2 (pt) | Composto, uso de um composto, composição farmacêutica, e, método de tratamento de um dispositivo de dor | |
BRPI0518829A2 (pt) | mÉtodo para o tratamento de dor neuropÁtica e sÍndromes associadas | |
EA200601776A1 (ru) | Метадоновые композиции местного действия и способы их применения | |
BRPI0615150A2 (pt) | agente para a profilaxia ou tratamento de diabete, sensibilizador de insulina, composto, pró-droga, agente farmacêutico, e, uso do composto ou um sal do mesmo ou uma pró-droga do mesmo | |
BRPI0517701A8 (pt) | métodos de tratamento de diabetes mellitus | |
ATE486860T1 (de) | Phenothiazin-derivat zur wundheilung | |
MXPA05011208A (es) | Uso de ivermectina para el tratamiento de desordenes dermatologicos. | |
BRPI0510094A (pt) | uso de flibanserina no tratamento pré-menstrual e outros distúrbios sexuais femininos | |
BRPI0511995A (pt) | uso de compostos peptìdicos para tratamento de dor em neuralgia trigeminal | |
BRPI0516519A (pt) | formulações de cuidado do cabelo compreendendo poliorganossiloxano aminofuncional | |
MY148459A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression | |
BRPI0819087A2 (pt) | Composição estabilizada, e, método para a estabilização de um produto para cuidado corporal, um produto doméstico, produto têxtil ou tecido | |
EA200601288A1 (ru) | Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение | |
BRPI0409359A (pt) | análogos quiméricos de somatostatina-dopamina | |
MX2009004770A (es) | Compuestos de carbamato para usarse en el tratamiento de la depresion. | |
BRPI0810773A2 (pt) | Composição farmacêutica, métodos para tratar dor em um mamífero, para tratar depressão em um mamífero, para tratar um distúrbio em um paciente, para fabricar um composto, e para inibir a captação de norepinefrina, composto, e, uso de uma composição. | |
EA200800537A1 (ru) | Маррубиин и композиция для уменьшения храпа, упаковка и методика | |
BRPI0411208A (pt) | uso de derivados 2-amino-1,3-propanodiol para a fabricação de um medicamento para o tratamento de vários tipos de dor | |
ATE416785T1 (de) | Therapeutische anwendungen für c-peptid | |
FR2885128B1 (fr) | Composition cosmetique a visee depigmentante ou eclaircissante comprenant au moins une oxazoline, a titre de principe actif depigmentant ou eclaircissant | |
ECSP066954A (es) | Compuestos peptídicos para tratar dolor en neuropatía diabética dolorosa | |
ATE437624T1 (de) | Topische zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: UCB PHARMA GMBH (DE) Free format text: NOME ALTERADO DE: SCHWARZ PHARMA AG |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013. |